logo
Share SHARE
FONT-SIZE Plus   Neg

ADP Names Dermot O'Brien Chief Human Resources Officer

Automatic Data Processing, Inc. (ADP), a provider of human resource outsourcing, payroll services, benefits administration and integrated computing solutions for vehicle dealers, on Monday said Dermot O'Brien has been appointed as the company's new Chief Human Resources Officer and Corporate Vice President.

O'Brien will serve as a member of ADP's Executive Committee and report directly to ADP President and Chief Executive Officer Carlos Rodriguez.

He will work closely with ADP's senior leadership team to develop workforce plans and programs. His responsibilities will include forecasting ADP's global talent needs, implementing initiatives that attract, develop, deploy and retain a diverse talent population, overseeing succession planning and management development as well as improving ADP's already strong levels of employee engagement.

O'Brien joins ADP from Fortune 100 company TIAA-CREF, where he served as Executive Vice President of Human Resources and as a member of its executive management team for nine years. Prior to that, he served as First Vice President, Human Resources at Merrill Lynch.

Commenting on O'Brien's appointment, Rodriguez said, "His broad human capital management expertise, proven track record of achievement, and reputation for operating with the highest integrity make him the ideal person to lead our global HR function, which currently serves more than 56,000 ADP associates around the world."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT